Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.63 USD | -2.85% | -7.27% | -20.47% |
04-25 | Top Premarket Gainers | MT |
04-25 | North American Morning Briefing : More Tech -2- | DJ |
Sales 2024 * | 33.61M 2.69B | Sales 2025 * | 64.29M 5.15B | Capitalization | 57.61M 4.61B |
---|---|---|---|---|---|
Net income 2024 * | -47M -3.76B | Net income 2025 * | 5M 400M | EV / Sales 2024 * | 1.71 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
-1.3
x | P/E ratio 2025 * |
2.48
x | Employees | 69 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Latest transcript on Cidara Therapeutics, Inc.
1 day | -2.85% | ||
1 week | -7.27% | ||
Current month | -31.36% | ||
1 month | -14.66% | ||
3 months | -5.02% | ||
6 months | -21.89% | ||
Current year | -20.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 31/12/13 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 31/08/21 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 31/12/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 31/03/14 |
Director/Board Member | 69 | 31/03/14 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 31/12/13 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 12.63 | -2.85% | 200,108 |
25/04/24 | 13 | +5.78% | 753,807 |
24/04/24 | 12.29 | +19.90% | 326,436 |
23/04/24 | 10.25 | -0.27% | 96,083 |
22/04/24 | 10.28 | -24.54% | 192,657 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.47% | 57.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CDTX Stock